RELA and hepatocellular carcinoma: Among these alterations, 51.6% (16/31) of the cases were identified as missense point mutations, deep deletion or associated with low mRNA expression (Figure S3E, Supporting Information), reinforcing the potential role of RELA deficiency in HCC pathogenesis.